| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glutathione binding | 1.28e-06 | 18 | 93 | 4 | GO:0043295 | |
| GeneOntologyMolecularFunction | oligopeptide binding | 2.02e-06 | 20 | 93 | 4 | GO:1900750 | |
| GeneOntologyMolecularFunction | glutathione transferase activity | 9.58e-06 | 29 | 93 | 4 | GO:0004364 | |
| GeneOntologyMolecularFunction | transferase activity, transferring alkyl or aryl (other than methyl) groups | 1.21e-05 | 64 | 93 | 5 | GO:0016765 | |
| GeneOntologyMolecularFunction | phosphatidate cytidylyltransferase activity | 6.42e-05 | 3 | 93 | 2 | GO:0004605 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase inhibitor activity | 1.32e-04 | 105 | 93 | 5 | GO:0004867 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC6A7 TOMM7 SLC29A3 SLC11A1 MFSD14B SLC43A1 ABCB11 BEST3 ABCC9 CTNS GRIN2C SPNS3 ABCA10 NDUFC1 SLC37A4 | 3.46e-04 | 1180 | 93 | 15 | GO:0022857 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC6A7 SLC29A3 SLC11A1 ABCB11 ABCC9 CTNS ABCA10 NDUFC1 SLC37A4 | 3.83e-04 | 477 | 93 | 9 | GO:0022804 |
| GeneOntologyMolecularFunction | transporter activity | SLC6A7 TOMM7 SLC29A3 SLC11A1 MFSD14B SLC43A1 ABCB11 BEST3 ABCC9 CTNS GRIN2C SPNS3 ABCA10 NDUFC1 SLC37A4 | 8.68e-04 | 1289 | 93 | 15 | GO:0005215 |
| GeneOntologyMolecularFunction | cytidylyltransferase activity | 9.42e-04 | 10 | 93 | 2 | GO:0070567 | |
| GeneOntologyMolecularFunction | acetylglucosaminyltransferase activity | 1.37e-03 | 47 | 93 | 3 | GO:0008375 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 1.47e-03 | 105 | 93 | 4 | GO:0015171 | |
| GeneOntologyMolecularFunction | endopeptidase inhibitor activity | 1.54e-03 | 180 | 93 | 5 | GO:0004866 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 1.54e-03 | 49 | 93 | 3 | GO:0140359 | |
| GeneOntologyBiologicalProcess | nitrobenzene metabolic process | 3.42e-07 | 4 | 92 | 3 | GO:0018916 | |
| GeneOntologyBiologicalProcess | glutathione metabolic process | 9.07e-06 | 63 | 92 | 5 | GO:0006749 | |
| GeneOntologyBiologicalProcess | xenobiotic catabolic process | 2.19e-05 | 37 | 92 | 4 | GO:0042178 | |
| GeneOntologyBiologicalProcess | lipid droplet formation | 3.76e-05 | 15 | 92 | 3 | GO:0140042 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 4.04e-05 | 141 | 92 | 6 | GO:0006805 | |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | 6.14e-05 | 222 | 92 | 7 | GO:0071466 | |
| Domain | GST_mu | 2.75e-09 | 5 | 92 | 4 | IPR003081 | |
| Domain | GST_N | 3.77e-06 | 22 | 92 | 4 | PF02798 | |
| Domain | GST_NTER | 3.77e-06 | 22 | 92 | 4 | PS50404 | |
| Domain | GST_C | 7.59e-06 | 26 | 92 | 4 | IPR004046 | |
| Domain | GST_C | 7.59e-06 | 26 | 92 | 4 | PF00043 | |
| Domain | Glutathione_S-Trfase_N | 8.87e-06 | 27 | 92 | 4 | IPR004045 | |
| Domain | GST_CTER | 2.28e-05 | 34 | 92 | 4 | PS50405 | |
| Domain | PC_trans | 2.40e-05 | 2 | 92 | 2 | IPR000374 | |
| Domain | CDS | 2.40e-05 | 2 | 92 | 2 | PS01315 | |
| Domain | PC_Trfase_euk | 2.40e-05 | 2 | 92 | 2 | IPR016720 | |
| Domain | Glutathione-S-Trfase_C-like | 3.97e-05 | 39 | 92 | 4 | IPR010987 | |
| Domain | - | 3.97e-05 | 39 | 92 | 4 | 1.20.1050.10 | |
| Domain | MFS_1 | 5.67e-04 | 77 | 92 | 4 | PF07690 | |
| Domain | MFS | 5.67e-04 | 77 | 92 | 4 | IPR011701 | |
| Domain | Serpin_dom | 7.34e-04 | 36 | 92 | 3 | IPR023796 | |
| Domain | SERPIN | 7.96e-04 | 37 | 92 | 3 | SM00093 | |
| Domain | SERPIN | 7.96e-04 | 37 | 92 | 3 | PS00284 | |
| Domain | Serpin | 8.61e-04 | 38 | 92 | 3 | PF00079 | |
| Domain | Serpin_fam | 9.30e-04 | 39 | 92 | 3 | IPR000215 | |
| Domain | GST_C_3 | 1.05e-03 | 10 | 92 | 2 | PF14497 | |
| Domain | ABC_transporter_CS | 1.16e-03 | 42 | 92 | 3 | IPR017871 | |
| Domain | DUF4599 | 1.53e-03 | 12 | 92 | 2 | PF15371 | |
| Domain | DUF4599 | 1.53e-03 | 12 | 92 | 2 | IPR027970 | |
| Domain | ubiquitin | 1.60e-03 | 47 | 92 | 3 | PF00240 | |
| Domain | ABC_tran | 1.70e-03 | 48 | 92 | 3 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 1.70e-03 | 48 | 92 | 3 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 1.81e-03 | 49 | 92 | 3 | PS00211 | |
| Domain | ABC_transporter-like | 1.92e-03 | 50 | 92 | 3 | IPR003439 | |
| Domain | - | 2.10e-03 | 14 | 92 | 2 | 2.60.40.420 | |
| Domain | UBIQUITIN_2 | 2.39e-03 | 54 | 92 | 3 | PS50053 | |
| Domain | Ubiquitin_dom | 2.93e-03 | 58 | 92 | 3 | IPR000626 | |
| Domain | - | 3.11e-03 | 122 | 92 | 4 | 3.40.30.10 | |
| Domain | Thioredoxin-like_fold | 4.12e-03 | 132 | 92 | 4 | IPR012336 | |
| Domain | MFS_dom | 4.35e-03 | 134 | 92 | 4 | IPR020846 | |
| Domain | Cupredoxin | 5.20e-03 | 22 | 92 | 2 | IPR008972 | |
| Domain | PDZ | 5.21e-03 | 141 | 92 | 4 | PF00595 | |
| Domain | PDZ | 6.17e-03 | 148 | 92 | 4 | SM00228 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_DCE_TO_DNA_ADDUCTS | 2.29e-06 | 19 | 72 | 4 | M47809 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_TCDD_TO_AHR_SIGNALING_PATHWAY | 5.15e-06 | 23 | 72 | 4 | M47806 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KEAP1_NRF2_SIGNALING_PATHWAY | 6.15e-06 | 24 | 72 | 4 | M47487 | |
| Pathway | REACTOME_GLUTATHIONE_CONJUGATION | 3.26e-05 | 36 | 72 | 4 | M1443 | |
| Pathway | REACTOME_GLUTATHIONE_CONJUGATION | 4.05e-05 | 38 | 72 | 4 | MM14600 | |
| Pathway | KEGG_GLUTATHIONE_METABOLISM | 1.21e-04 | 50 | 72 | 4 | M1840 | |
| Pathway | WP_GLUTATHIONE_METABOLISM | 3.42e-04 | 27 | 72 | 3 | MM15908 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 4.45e-04 | 70 | 72 | 4 | M16794 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 4.95e-04 | 72 | 72 | 4 | M9257 | |
| Pubmed | 2.50e-10 | 5 | 94 | 4 | 19856098 | ||
| Pubmed | 2.50e-10 | 5 | 94 | 4 | 18551009 | ||
| Pubmed | 1.91e-08 | 3 | 94 | 3 | 8471052 | ||
| Pubmed | Small Extracellular Vesicles Have GST Activity and Ameliorate Senescence-Related Tissue Damage. | 1.91e-08 | 3 | 94 | 3 | 32574561 | |
| Pubmed | 1.91e-08 | 3 | 94 | 3 | 9452477 | ||
| Pubmed | 1.91e-08 | 3 | 94 | 3 | 16549767 | ||
| Pubmed | 7.63e-08 | 4 | 94 | 3 | 22406107 | ||
| Pubmed | 7.63e-08 | 4 | 94 | 3 | 8373352 | ||
| Pubmed | Identification of class-mu glutathione transferase genes GSTM1-GSTM5 on human chromosome 1p13. | 7.63e-08 | 4 | 94 | 3 | 8317488 | |
| Pubmed | Variation in the GST mu locus and tobacco smoke exposure as determinants of childhood lung function. | 7.63e-08 | 4 | 94 | 3 | 19151192 | |
| Pubmed | 3.80e-07 | 6 | 94 | 3 | 1530570 | ||
| Pubmed | 9.89e-07 | 193 | 94 | 7 | 19343046 | ||
| Pubmed | 1.30e-06 | 30 | 94 | 4 | 20200426 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 2689439 | ||
| Pubmed | Genomic organization and characterization of the promoter region of murine GSTM2 gene. | 7.23e-06 | 2 | 94 | 2 | 11404019 | |
| Pubmed | Structure of human glutathione S-transferase class Mu genes. | 7.23e-06 | 2 | 94 | 2 | 2006920 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 3174634 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 6500576 | ||
| Pubmed | Isolation and characterization of murine Cds (CDP-diacylglycerol synthase) 1 and 2. | 7.23e-06 | 2 | 94 | 2 | 16023307 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 26098720 | ||
| Pubmed | Distinct properties of the two isoforms of CDP-diacylglycerol synthase. | 7.23e-06 | 2 | 94 | 2 | 25375833 | |
| Pubmed | Cloning and expression of a novel Mu class murine glutathione transferase isoenzyme. | 7.23e-06 | 2 | 94 | 2 | 12069689 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 24048194 | ||
| Pubmed | The role of mannosylated enzyme and the mannose receptor in enzyme replacement therapy. | 7.23e-06 | 2 | 94 | 2 | 16380916 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 8909248 | ||
| Pubmed | CDP-DAG synthase 1 and 2 regulate lipid droplet growth through distinct mechanisms. | 7.23e-06 | 2 | 94 | 2 | 31548309 | |
| Pubmed | DNA methylation is associated with altered gene expression in AMD. | 7.23e-06 | 2 | 94 | 2 | 22410570 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 12486119 | ||
| Pubmed | Isolation and chromosomal localization of two human CDP-diacylglycerol synthase (CDS) genes. | 7.23e-06 | 2 | 94 | 2 | 9806839 | |
| Pubmed | CDP-diacylglycerol synthases regulate the growth of lipid droplets and adipocyte development. | 7.23e-06 | 2 | 94 | 2 | 26946540 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 24399650 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 23675469 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 18692819 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 12192076 | ||
| Pubmed | GSTM1 and GSTM5 Genetic Polymorphisms and Expression in Age-Related Macular Degeneration. | 7.23e-06 | 2 | 94 | 2 | 25897651 | |
| Pubmed | Glycosylation regulates NK cell-mediated effector function through PI3K pathway. | 7.23e-06 | 2 | 94 | 2 | 20089585 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 26109616 | ||
| Pubmed | MIA2 COPA PIK3C2A USP9X DHCR7 CDS2 DDX42 NUP188 LRBA HERPUD1 SLC37A4 FKBP5 NCDN | 1.57e-05 | 1168 | 94 | 13 | 19946888 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 10580127 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 19403558 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 16842493 | ||
| Pubmed | Purification and characterization of glutathione S-transferase of murine ovary and testis. | 2.16e-05 | 3 | 94 | 2 | 8442656 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 27601211 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 8512323 | ||
| Pubmed | Genetic susceptibility, residential radon, and lung cancer in a radon prone area. | 2.16e-05 | 3 | 94 | 2 | 24852519 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 24726881 | ||
| Pubmed | Biosynthesis of 14,15-hepoxilins in human l1236 Hodgkin lymphoma cells and eosinophils. | 2.16e-05 | 3 | 94 | 2 | 21046276 | |
| Pubmed | Immunohistochemical and microarray analyses of a mouse model for the smith-lemli-opitz syndrome. | 2.16e-05 | 3 | 94 | 2 | 16280635 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 16002077 | ||
| Pubmed | Glutathione-S-transferases and Chemotherapy Resistance of Hodgkin's Lymphoma Cell Lines. | 2.16e-05 | 3 | 94 | 2 | 27466493 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 23671930 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 8473333 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 10587441 | ||
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 28423700 | ||
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 9407135 | ||
| Pubmed | p38alpha MAP kinase as a sensor of reactive oxygen species in tumorigenesis. | 4.32e-05 | 4 | 94 | 2 | 17292829 | |
| Pubmed | Proteome-wide characterization of N-glycosylation events by diagonal chromatography. | 5.82e-05 | 77 | 94 | 4 | 16944957 | |
| Pubmed | Cloning and characterization of a novel class II phosphoinositide 3-kinase containing C2 domain. | 7.19e-05 | 5 | 94 | 2 | 9514948 | |
| Pubmed | The consensus coding sequences of human breast and colorectal cancers. | 7.19e-05 | 5 | 94 | 2 | 16959974 | |
| Pubmed | 1.08e-04 | 6 | 94 | 2 | 27323100 | ||
| Pubmed | 1.08e-04 | 6 | 94 | 2 | 19812333 | ||
| Pubmed | CD73 Activity is Dispensable for the Polarization of M2 Macrophages. | 1.08e-04 | 6 | 94 | 2 | 26258883 | |
| Pubmed | 1.08e-04 | 6 | 94 | 2 | 24619415 | ||
| Pubmed | 1.50e-04 | 7 | 94 | 2 | 12659817 | ||
| Pubmed | 1.50e-04 | 7 | 94 | 2 | 8584275 | ||
| Pubmed | 1.50e-04 | 7 | 94 | 2 | 9889000 | ||
| Pubmed | 1.50e-04 | 7 | 94 | 2 | 16015370 | ||
| Pubmed | 2.18e-04 | 43 | 94 | 3 | 24172014 | ||
| Pubmed | Sox9-dependent expression of Gstm6 in Sertoli cells during testis development in mice. | 2.57e-04 | 9 | 94 | 2 | 19098141 | |
| Pubmed | 2.57e-04 | 9 | 94 | 2 | 10704386 | ||
| Pubmed | [Analysis of genetic predisposition to pulmonary tuberculosis in native Russians]. | 2.57e-04 | 9 | 94 | 2 | 20297661 | |
| Pubmed | 2.57e-04 | 9 | 94 | 2 | 18065725 | ||
| Pubmed | 2.57e-04 | 9 | 94 | 2 | 10683176 | ||
| Pubmed | 2.91e-04 | 332 | 94 | 6 | 37433992 | ||
| Pubmed | 2.94e-04 | 117 | 94 | 4 | 18977241 | ||
| Pubmed | 3.13e-04 | 119 | 94 | 4 | 17601350 | ||
| Pubmed | Interstitial microRNA miR-214 attenuates inflammation and polycystic kidney disease progression. | 3.21e-04 | 10 | 94 | 2 | 32182218 | |
| Pubmed | Neurodegeneration with Brain Iron Accumulation Disorders Overview | 3.21e-04 | 10 | 94 | 2 | 23447832 | |
| Pubmed | 3.91e-04 | 11 | 94 | 2 | 19910543 | ||
| Pubmed | 3.91e-04 | 11 | 94 | 2 | 15100242 | ||
| Pubmed | Mitochondrial Dysfunction Prevents Repolarization of Inflammatory Macrophages. | 3.91e-04 | 11 | 94 | 2 | 27732846 | |
| Pubmed | 4.12e-04 | 230 | 94 | 5 | 35449600 | ||
| Pubmed | 4.16e-04 | 657 | 94 | 8 | 36180527 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 4.54e-04 | 1024 | 94 | 10 | 24711643 | |
| Pubmed | Multiple influences on the migration of precerebellar neurons in the caudal medulla. | 4.69e-04 | 12 | 94 | 2 | 11807023 | |
| Pubmed | 4.69e-04 | 12 | 94 | 2 | 24009623 | ||
| Pubmed | Enhanced analysis of the mouse plasma proteome using cysteine-containing tryptic glycopeptides. | 5.57e-04 | 59 | 94 | 3 | 17330941 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | HAUS6 SLC29A3 EFNB1 LMO7 USP9X NUP188 LRBA FITM2 SLC37A4 CEMIP2 | 5.97e-04 | 1061 | 94 | 10 | 33845483 |
| Pubmed | 6.81e-04 | 257 | 94 | 5 | 16335952 | ||
| Pubmed | 7.73e-04 | 66 | 94 | 3 | 19898482 | ||
| Pubmed | 8.26e-04 | 405 | 94 | 6 | 38187761 | ||
| Pubmed | 8.46e-04 | 16 | 94 | 2 | 25211233 | ||
| Pubmed | 9.57e-04 | 17 | 94 | 2 | 28634350 | ||
| Pubmed | 9.99e-04 | 162 | 94 | 4 | 15174051 | ||
| Pubmed | 1.17e-03 | 76 | 94 | 3 | 19336475 | ||
| Pubmed | Cancer-associated FBXW7 loss is synthetic lethal with pharmacological targeting of CDC7. | 1.33e-03 | 175 | 94 | 4 | 37866880 | |
| Pubmed | 1.33e-03 | 20 | 94 | 2 | 20716560 | ||
| Pubmed | 1.47e-03 | 21 | 94 | 2 | 21273545 | ||
| Pubmed | 1.47e-03 | 21 | 94 | 2 | 15014966 | ||
| Pubmed | Noncoding RNA MaIL1 is an integral component of the TLR4-TRIF pathway. | 1.61e-03 | 22 | 94 | 2 | 32241891 | |
| Interaction | GSTM5 interactions | 4.89e-07 | 15 | 90 | 4 | int:GSTM5 | |
| Interaction | GSTM2 interactions | 2.56e-06 | 22 | 90 | 4 | int:GSTM2 | |
| Cytoband | 1p13.3 | 1.29e-05 | 69 | 94 | 4 | 1p13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p13 | 7.70e-05 | 211 | 94 | 5 | chr1p13 | |
| Cytoband | 4q21.23 | 3.19e-04 | 13 | 94 | 2 | 4q21.23 | |
| Cytoband | 9q21.32 | 6.93e-04 | 19 | 94 | 2 | 9q21.32 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q21 | 7.70e-04 | 199 | 94 | 4 | chr9q21 | |
| GeneFamily | Glutathione S-transferases | 2.31e-06 | 25 | 69 | 4 | 567 | |
| GeneFamily | Serpin peptidase inhibitors | 3.77e-04 | 37 | 69 | 3 | 739 | |
| GeneFamily | Mannosyl-glycoprotein N-acetylglucosaminyltransferases | 5.08e-04 | 9 | 69 | 2 | 435 | |
| GeneFamily | PDZ domain containing | 2.72e-03 | 152 | 69 | 4 | 1220 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.95e-08 | 168 | 94 | 7 | b98af4043dfa5dfa4413e482879fad88de484675 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.95e-08 | 168 | 94 | 7 | 073b53d4cee6bc8c5c6fce51cf6cd9c316478f69 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.28e-07 | 200 | 94 | 7 | 07d942803360e1a1e8e131d6e31c726dd0db1a0b | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Erythroid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.25e-07 | 144 | 94 | 6 | 1b9e95e4f6e40042d3cf2f94c067f3a6b19428ea | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Pericentral)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-06 | 160 | 94 | 6 | c42bcc6c7d113f0db43febb088b75ca4ac7cb7a3 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Pericentral_and_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-06 | 165 | 94 | 6 | d449a568664a81d9b5538e8f409301448a32ac37 | |
| ToppCell | droplet-Liver-HEPATOCYTES|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-06 | 169 | 94 | 6 | f195467438c589f87224bde7da720dea072d110c | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-06 | 169 | 94 | 6 | 7785cab967a33560830c394c918d6ce625103858 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam____podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-06 | 180 | 94 | 6 | 6327c938a4f99df9fee714e44f15ea4a4a63ae15 | |
| ToppCell | facs-GAT-Fat-3m|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-06 | 190 | 94 | 6 | 1d92be1b41cff59e834a9d28868f554bd1f3e471 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.64e-06 | 195 | 94 | 6 | 4cbc36fb3ef9aef61367d3b37070a9a85fae1418 | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-06 | 196 | 94 | 6 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-06 | 196 | 94 | 6 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 3.86e-06 | 197 | 94 | 6 | 30dbc05ea66892d2e18ff375ffa86d1db7bc4083 | |
| ToppCell | Healthy_donor-cDC|Healthy_donor / disease group, cell group and cell class (v2) | 3.86e-06 | 197 | 94 | 6 | b57a27e5b855bbdd1dfa352540599d260dc482aa | |
| ToppCell | Healthy/Control-cDC|World / Disease group and Cell class | 3.86e-06 | 197 | 94 | 6 | 4497d4073f4d3e74de907325fba9eb4af5766bf4 | |
| ToppCell | Healthy_donor-cDC|World / disease group, cell group and cell class (v2) | 3.86e-06 | 197 | 94 | 6 | a545fe3a80cd721bf01115bbb645753840ec9f40 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.21e-06 | 200 | 94 | 6 | d0812817ef99608994193787a62d39adeb2070ca | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.21e-06 | 200 | 94 | 6 | cd54ddf1919c98e84b7e4aba85b374fc8b407206 | |
| ToppCell | Epithelial-Epithelial-D_(Clara-Club_cells)|Epithelial / shred on cell class and cell subclass (v4) | 6.36e-06 | 123 | 94 | 5 | caa1576f1b5eb592d522be61c090ac444e277ac5 | |
| ToppCell | PND28-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.41e-05 | 145 | 94 | 5 | 9b69bfdbf91ef197b4c483617aa67498d9d2cd79 | |
| ToppCell | PND28-Epithelial-Epithelial_Airway-Neurosecretory-Secretory|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.41e-05 | 145 | 94 | 5 | 31af9fce1dcd7e8ae1604476598e099232017ee9 | |
| ToppCell | PND28-Epithelial-Epithelial_Airway-Neurosecretory|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.41e-05 | 145 | 94 | 5 | 76f0cde9acdc3ad5948c007dccf312665972c9e6 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-05 | 159 | 94 | 5 | 7ad3a91d29639b32f6264c91f401c14a35469ac0 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.34e-05 | 161 | 94 | 5 | c4970501c038ed36de447da70eabff020ad78713 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Neurosecretory-Secretory|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.34e-05 | 161 | 94 | 5 | 41a89a3d99a9bd6039a3d881d1d9dcd18bc07f25 | |
| ToppCell | PND14-Epithelial-Epithelial_Airway-Neurosecretory|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.63e-05 | 165 | 94 | 5 | 6fdce8b23736409a23884ef3918638ffc067a86f | |
| ToppCell | PND14-Epithelial-Epithelial_Airway-Neurosecretory-Secretory|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.63e-05 | 165 | 94 | 5 | dd4d36ff8efb89fee1fb4c48d1b8f46902119909 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.63e-05 | 165 | 94 | 5 | 62457b7b74c6eae42d91d65e7dc6df6bf8e061f7 | |
| ToppCell | PND14-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.63e-05 | 165 | 94 | 5 | baff639a7046fb5cacb70f341b6d24cef3519f8e | |
| ToppCell | COVID_vent-Lymphocytic-Dendritic-pDC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.12e-05 | 171 | 94 | 5 | 779c951d274ecbd1d546ac425d6c8e718623be5a | |
| ToppCell | COVID_vent-Lymphocytic-Dendritic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.12e-05 | 171 | 94 | 5 | debbb071d260639b16269c94d172766908325c58 | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-05 | 173 | 94 | 5 | 8bffd512a4e561e23cc04478e2ca6fd5d3771fe4 | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-05 | 173 | 94 | 5 | 3e3c61468e703330788a10d850ef41a85680f86d | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.49e-05 | 175 | 94 | 5 | 5c38d4b6c03473d841e6203a7efaa6dcb2d59386 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Neurosecretory|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.10e-05 | 181 | 94 | 5 | 092a971661b0aa06c1cdf428dbfa7339a26fb678 | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-naive_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-05 | 182 | 94 | 5 | 8b16a13d8606d21a7a9ce1175237e9b4cf832ee0 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.43e-05 | 184 | 94 | 5 | 49eccf72725593a8fb4a529e7985a5c413b3ca6a | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory-Secretory|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.43e-05 | 184 | 94 | 5 | 41164109d9d7bb1c431220e2e85e08dc5f56856d | |
| ToppCell | facs-Brain_Myeloid-Cortex|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.43e-05 | 184 | 94 | 5 | 17f63dd671f9ff3dd2860d8de41b05c35c095950 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D175|Adult / Lineage, Cell type, age group and donor | 4.54e-05 | 185 | 94 | 5 | ab5704b96f1d368911308797d10c7c52766ab134 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-naive_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.54e-05 | 185 | 94 | 5 | 3f1aa91efae2d00320d126087cce1431ad5f26ea | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D231|Adult / Lineage, Cell type, age group and donor | 4.54e-05 | 185 | 94 | 5 | 07f9f38f0739d7c830641723a38385550ac1ac92 | |
| ToppCell | COVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type | 4.91e-05 | 188 | 94 | 5 | d582b76fc2faac526c9bf97503041129e1a6a211 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.03e-05 | 189 | 94 | 5 | c81b38cda4525254fe4fa137a4c9bc9abe0363bb | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.03e-05 | 189 | 94 | 5 | 807922b5ea0faddd3abfa9ec1b53f3f2b00e61bf | |
| ToppCell | COVID-19-lung-Vein_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.16e-05 | 190 | 94 | 5 | 1caeaef78326734c1e31a0c4739190d5c5a77b9e | |
| ToppCell | (1)_Osterolineage_cells-(10)_OLC-1|(1)_Osterolineage_cells / Cell class and subclass of bone marrow stroma cells in homeostatis | 5.29e-05 | 191 | 94 | 5 | 78ad7c555409ce1391bce406bc0f3ef575329ece | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.69e-05 | 194 | 94 | 5 | b16ed97eb6b7b7a220e943474c0d85c141b6e3a5 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.69e-05 | 194 | 94 | 5 | 2210f0755882d8f04edb4c109fb17c3f9149f6f7 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.69e-05 | 194 | 94 | 5 | 68004855b23fe1e31e8452d70effabc78a4a0bd3 | |
| ToppCell | COVID-19-kidney-Glomerular_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.69e-05 | 194 | 94 | 5 | 660535b492445063d965095a50e1e299ce04c50a | |
| ToppCell | (010)_cDC|World / immune cells in Peripheral Blood (logTPM normalization) | 5.83e-05 | 195 | 94 | 5 | 4aabb3f5ce70100e4d98d7fa9f8d12e84fb9fe3d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.83e-05 | 195 | 94 | 5 | 9651ee03738226ee10e901f8b9ec6a417eb9c301 | |
| ToppCell | PBMC-Control-Myeloid-cDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.98e-05 | 196 | 94 | 5 | e1f763fa9c11bf5f4d80e79f70f9485724ac23fe | |
| ToppCell | Control-Myeloid-cDC|Control / Disease group, lineage and cell class | 5.98e-05 | 196 | 94 | 5 | 85d92bc226cc28384c30991cc4ebb02ec2e3ec99 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.98e-05 | 196 | 94 | 5 | 553c22c7d48f3b4f6f2b2f10d6e668c5ebb09e8c | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.98e-05 | 196 | 94 | 5 | 0bac14c018487ca67e7f9255b5f186e7ae665774 | |
| ToppCell | PBMC-Control-Myeloid-cDC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.98e-05 | 196 | 94 | 5 | d376168e15ec1cf618723259966c76be3698b9b0 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.98e-05 | 196 | 94 | 5 | 33345338c825484960daa1ed82a19df38ccfc5c0 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.98e-05 | 196 | 94 | 5 | 4a9095ba3f6709f88f32bf09184553f4bd211f43 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-E|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.12e-05 | 197 | 94 | 5 | 9b1c1d72c5a8c90d71ae31e4c198d2276872eaa0 | |
| ToppCell | mild_COVID-19-cDC|World / disease group, cell group and cell class (v2) | 6.12e-05 | 197 | 94 | 5 | 63e7b040c64f1e28b8db79980c7b580caa7d1b95 | |
| ToppCell | Healthy/Control-cDC|Healthy/Control / Disease group and Cell class | 6.12e-05 | 197 | 94 | 5 | 926423aae9fcf654f84b0f7621103a6a22d3aced | |
| ToppCell | mild_COVID-19-cDC|mild_COVID-19 / disease group, cell group and cell class (v2) | 6.12e-05 | 197 | 94 | 5 | 44ebd3f967779bb7753fc6dcd9fde6d682f9ccd6 | |
| ToppCell | BL-critical-LOC-Epithelial|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.27e-05 | 198 | 94 | 5 | 6218a25b94d5fa2c69880539adf9c63bfe52dcd3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.27e-05 | 198 | 94 | 5 | 1378c6d4ceb84b42fdd6556be3296df7a8059e6e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.27e-05 | 198 | 94 | 5 | d0371e2ca9e25727b35985940f6228f9d8e49727 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.27e-05 | 198 | 94 | 5 | 92416e65a0dc1a4bf931833407620ea05d362f56 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.27e-05 | 198 | 94 | 5 | 08ad0bece508bb4f9cc126d94839b5c89ce21ba8 | |
| ToppCell | AT2_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 6.27e-05 | 198 | 94 | 5 | 893036558a9ad86b57f9e735df35812e9d18739e | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 6.27e-05 | 198 | 94 | 5 | 8689090bce9ab6e8f122426a404037e572c6713b | |
| ToppCell | distal-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.27e-05 | 198 | 94 | 5 | 6aef5f5f89b508b214e1ab1876a743dedda0553b | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.42e-05 | 199 | 94 | 5 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 | |
| ToppCell | COVID-19-kidney-Glomerular_EC|kidney / Disease (COVID-19 only), tissue and cell type | 6.42e-05 | 199 | 94 | 5 | fffd2f9042b55531dac4e5b463b5cee80402e7bb | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.58e-05 | 200 | 94 | 5 | 21d9cf3cd3696ad6b745c7c036798f04b6ce5160 | |
| ToppCell | Biopsy_Other_PF-Epithelial|Biopsy_Other_PF / Sample group, Lineage and Cell type | 6.58e-05 | 200 | 94 | 5 | 1ef4d5ae698fa721e0f510bf0d918bd8d3b00591 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.58e-05 | 200 | 94 | 5 | 33658d5d09e2eaff60f4dd88837d4252328eab63 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 6.58e-05 | 200 | 94 | 5 | d5426cd318a8f90c0bd8f9804351ab230fafc995 | |
| ToppCell | Parenchyma_Control_(B.)|World / Sample group, Lineage and Cell type | 6.58e-05 | 200 | 94 | 5 | 220b6e5f936b3d08b031d6cabc5793213b98b8e2 | |
| ToppCell | Biopsy_Other_PF-Epithelial-SCGB3A2+|Biopsy_Other_PF / Sample group, Lineage and Cell type | 6.58e-05 | 200 | 94 | 5 | 631550dc34bcb605ab726645f4024d7828bb7975 | |
| ToppCell | Club_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.80e-04 | 149 | 94 | 4 | 81c813588bb5efb7b31141a75d387210dcb76094 | |
| ToppCell | TCGA-Lung|World / Sample_Type by Project: Shred V9 | 2.87e-04 | 150 | 94 | 4 | 8c133206786e8f22bb70f2a7de9c0cb7f9ea9313 | |
| ToppCell | Int-URO-Other|Int-URO / Disease, Lineage and Cell Type | 2.94e-04 | 151 | 94 | 4 | ea5f25842e621be41a6491c9959d419d9cc7ebd6 | |
| ToppCell | Int-URO-Other-RBC|Int-URO / Disease, Lineage and Cell Type | 2.94e-04 | 151 | 94 | 4 | 0344d482f1c55c9eaa15beb8d6bac1c6cdca21b3 | |
| ToppCell | primary_visual_cortex-Non-neuronal-astrocyte|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.09e-04 | 153 | 94 | 4 | 95b28c5bd10ffb74c0993ebd565038b9818e4bd2 | |
| ToppCell | primary_visual_cortex-Non-neuronal-astrocyte-Astro|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.09e-04 | 153 | 94 | 4 | b09f8def40a1ea56722f3398f61a036667b61cd9 | |
| ToppCell | primary_visual_cortex-Non-neuronal-astrocyte-Astro-Astro_Aqp4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.09e-04 | 153 | 94 | 4 | 3ab9d55b3db51715c1d61eca142384195ce4b54f | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Alveolar_Mac|metastatic_Lymph_Node / Location, Cell class and cell subclass | 3.25e-04 | 155 | 94 | 4 | 03fd443740272dcb547e39deaf7ae89b8307f241 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.33e-04 | 156 | 94 | 4 | d72c2f5f72d269e29033f8728d924e0d4c8772c7 | |
| ToppCell | facs-Liver-Hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.33e-04 | 156 | 94 | 4 | e2cda3ad4e5f44a80133864c5a38b766afb952ce | |
| ToppCell | LPS-IL1RA-Hematopoietic_Meg-Ery-Mes-Epi-like|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.41e-04 | 157 | 94 | 4 | bd45590da540a557dc8096980a45220fccb99505 | |
| ToppCell | frontal_cortex-Non-neuronal-astrocyte-Astro|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.41e-04 | 157 | 94 | 4 | 0551442ae14685d8fe5729e3960c6324b1e05e4d | |
| ToppCell | frontal_cortex-Non-neuronal-astrocyte|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.41e-04 | 157 | 94 | 4 | 803af734d7f775d294391e2b84e472a732e18cef | |
| ToppCell | frontal_cortex-Non-neuronal-astrocyte-Astro-Astro_Aqp4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.41e-04 | 157 | 94 | 4 | 9aa5304a9704da6dd4eda7d6940494b00e38b2e8 | |
| ToppCell | LPS-IL1RA-Hematopoietic_Meg-Ery-Mes-Epi-like-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.41e-04 | 157 | 94 | 4 | 00c9a58b033b8b95b0d838f233dd077b62d8b02a | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Club|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.49e-04 | 158 | 94 | 4 | 03281e87780e3bacd089903383c016d03c373bf7 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.49e-04 | 158 | 94 | 4 | 9f58428f70d1427b20122c5c1cc7bf521d0f4832 | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 3.49e-04 | 158 | 94 | 4 | ab05f6d7968ccd6d3826cd71b763dbedc83822c3 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.58e-04 | 159 | 94 | 4 | 60b1f4dce2ce0911160fda17f137c064da31e2eb | |
| Computational | ROS metabolism. | 5.19e-06 | 22 | 58 | 4 | MODULE_310 | |
| Computational | Genes in the cancer module 101. | 1.74e-05 | 10 | 58 | 3 | MODULE_101 | |
| Computational | Genes in the cancer module 132. | 5.20e-05 | 14 | 58 | 3 | MODULE_132 | |
| Drug | sulfobromophthalein | 2.02e-07 | 103 | 92 | 7 | CID000005345 | |
| Drug | Lyndiol | 2.45e-07 | 34 | 92 | 5 | CID000082149 | |
| Drug | EUK-189 | 4.38e-07 | 16 | 92 | 4 | ctd:C436526 | |
| Drug | Clch2cosg | 7.31e-07 | 18 | 92 | 4 | CID000163913 | |
| Drug | C14791 | 7.31e-07 | 18 | 92 | 4 | CID011954044 | |
| Drug | C14793 | 7.31e-07 | 18 | 92 | 4 | CID011954046 | |
| Drug | C14803 | 7.31e-07 | 18 | 92 | 4 | CID011954054 | |
| Drug | C14805 | 7.31e-07 | 18 | 92 | 4 | CID011954056 | |
| Drug | C14804 | 7.31e-07 | 18 | 92 | 4 | CID011954055 | |
| Drug | C14806 | 7.31e-07 | 18 | 92 | 4 | CID011954057 | |
| Drug | C14848 | 7.31e-07 | 18 | 92 | 4 | CID011954067 | |
| Drug | C14856 | 7.31e-07 | 18 | 92 | 4 | CID011954069 | |
| Drug | C14855 | 7.31e-07 | 18 | 92 | 4 | CID011954068 | |
| Drug | S-(2,2-dichloro-1-hydroxy)ethylglutathione | 7.31e-07 | 18 | 92 | 4 | CID011954070 | |
| Drug | AC1L4MYY | 7.31e-07 | 18 | 92 | 4 | CID000188517 | |
| Drug | 2-(S-glutathionyl) acetyl glutathione | 1.15e-06 | 20 | 92 | 4 | CID011954072 | |
| Drug | C14865 | 1.15e-06 | 20 | 92 | 4 | CID011954073 | |
| Drug | 1-chloro-2,4-dinitrobenzene-glutathione conjugate | 1.27e-06 | 6 | 92 | 3 | ctd:C042630 | |
| Drug | S-(formylmethyl)glutathione | 2.49e-06 | 24 | 92 | 4 | CID011954074 | |
| Drug | AC1Q608X | 4.75e-06 | 28 | 92 | 4 | CID000128466 | |
| Drug | AC1L33DC | 4.75e-06 | 28 | 92 | 4 | CID000133757 | |
| Drug | BP-4,5-oxide | 4.80e-06 | 61 | 92 | 5 | CID000037786 | |
| Drug | Phlorhizin | 5.05e-06 | 235 | 92 | 8 | ctd:D010695 | |
| Drug | 2-BHA | 5.49e-06 | 29 | 92 | 4 | CID000006932 | |
| Drug | Dcvg | 7.22e-06 | 31 | 92 | 4 | CID006437359 | |
| Drug | o-dinitrobenzene | 7.22e-06 | 31 | 92 | 4 | CID000010707 | |
| Drug | zinc sulfate | 8.85e-06 | 69 | 92 | 5 | CID000024424 | |
| Drug | 4-propylphenol | 1.03e-05 | 11 | 92 | 3 | ctd:C099327 | |
| Drug | glutathione reduced | GSTM1 GSTM2 GSTM4 GSTM5 SLC6A7 DAND5 PIK3C2A ABCB11 CP CTNS GRIN2C | 1.03e-05 | 534 | 92 | 11 | CID000000745 |
| Drug | m-toluidine | 1.06e-05 | 34 | 92 | 4 | CID000007934 | |
| Drug | dimethoxystrychnine | 1.19e-05 | 35 | 92 | 4 | CID000009649 | |
| Drug | Dixan | 1.19e-05 | 35 | 92 | 4 | CID000010404 | |
| Drug | Glutathione | 1.33e-05 | 36 | 92 | 4 | DB00143 | |
| Drug | Glutathione S-(2,4 Dinitrobenzene) | 1.62e-05 | 2 | 92 | 2 | DB02458 | |
| Drug | cobaltocene | 1.62e-05 | 2 | 92 | 2 | CID000092884 | |
| Drug | Beta-sistosterol [83-46-5]; Up 200; 9.6uM; HL60; HT_HG-U133A | 1.69e-05 | 200 | 92 | 7 | 2912_UP | |
| Drug | Ethoxyquin | 2.04e-05 | 40 | 92 | 4 | ctd:D005015 | |
| Drug | 4-hydroxyanisole | 3.58e-05 | 46 | 92 | 4 | CID000009015 | |
| Drug | oxidized glutathione | 3.81e-05 | 227 | 92 | 7 | CID000000975 | |
| Drug | C14802 | 3.90e-05 | 47 | 92 | 4 | CID011954053 | |
| Drug | C14800 | 4.24e-05 | 48 | 92 | 4 | CID011954051 | |
| Drug | felbamate | 4.24e-05 | 48 | 92 | 4 | ctd:C047360 | |
| Drug | bromobenzene-3,4-oxide | 4.60e-05 | 49 | 92 | 4 | CID000108121 | |
| Drug | NSC-339901 | 4.83e-05 | 3 | 92 | 2 | CID000433934 | |
| Drug | phenanthroline | 4.99e-05 | 50 | 92 | 4 | CID000067473 | |
| Drug | bromobenzene-2,3-oxide | 4.99e-05 | 50 | 92 | 4 | CID003036760 | |
| Drug | 1,1-dichloroethylene epoxide | 4.99e-05 | 50 | 92 | 4 | CID000119521 | |
| Drug | naphthalene epoxide | 5.39e-05 | 51 | 92 | 4 | CID000108063 | |
| Drug | ethyl vinyl ether | 5.90e-05 | 19 | 92 | 3 | CID000008023 | |
| Drug | dichloroacetaldehyde | 6.76e-05 | 54 | 92 | 4 | CID000006576 | |
| Drug | chloroacetyl chloride | 7.27e-05 | 55 | 92 | 4 | CID000006577 | |
| Drug | S-hexylglutathione | 7.27e-05 | 55 | 92 | 4 | CID000005140 | |
| Drug | oltipraz | 7.81e-05 | 56 | 92 | 4 | ctd:C026209 | |
| Drug | AC1L973H | 8.37e-05 | 57 | 92 | 4 | CID000439306 | |
| Drug | cyclohexanone | 8.37e-05 | 57 | 92 | 4 | CID000007967 | |
| Drug | tiadenol | 8.37e-05 | 57 | 92 | 4 | CID000023403 | |
| Drug | perhexiline | 8.96e-05 | 58 | 92 | 4 | CID000004746 | |
| Drug | bromoacetaldehyde | 8.96e-05 | 58 | 92 | 4 | CID000105131 | |
| Drug | diepoxybutane | 9.61e-05 | 113 | 92 | 5 | CID000011254 | |
| Drug | sulfolithocholic acid | 9.64e-05 | 4 | 92 | 2 | ctd:C014202 | |
| Drug | 4-chloronitrobenzene | 9.64e-05 | 4 | 92 | 2 | ctd:C010407 | |
| Drug | Deladroxone | 9.64e-05 | 4 | 92 | 2 | CID000032327 | |
| Drug | piriprost | 1.02e-04 | 60 | 92 | 4 | CID006437373 | |
| Drug | 3,4,5,3',4'-pentachlorobiphenyl | GSTM1 ZDHHC2 GSTM2 GSTM5 MGAT3 EFNB1 UTP25 LMO7 ESR2 DHCR7 CP CPA2 SLC37A4 RUFY3 SMAD9 | 1.05e-04 | 1219 | 92 | 15 | ctd:C023035 |
| Drug | PenCB | 1.09e-04 | 61 | 92 | 4 | CID000036188 | |
| Drug | NSC39143 | 1.09e-04 | 61 | 92 | 4 | CID000002579 | |
| Drug | Butylated Hydroxyanisole | 1.18e-04 | 118 | 92 | 5 | ctd:D002083 | |
| Drug | DNCB | 1.19e-04 | 189 | 92 | 6 | CID000000006 | |
| Drug | Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 1.30e-04 | 192 | 92 | 6 | 4746_DN | |
| Drug | Trioxsalen [3902-71-4]; Up 200; 17.6uM; PC3; HT_HG-U133A | 1.45e-04 | 196 | 92 | 6 | 5736_UP | |
| Drug | AC1NSK22 | 1.49e-04 | 66 | 92 | 4 | CID005311131 | |
| Drug | dicyclanil | 1.49e-04 | 124 | 92 | 5 | ctd:C121718 | |
| Drug | Lisuride (S)(-) [18016-80-3]; Down 200; 11.8uM; PC3; HG-U133A | 1.50e-04 | 197 | 92 | 6 | 1962_DN | |
| Drug | Etofylline [519-37-9]; Up 200; 17.8uM; MCF7; HT_HG-U133A | 1.50e-04 | 197 | 92 | 6 | 5467_UP | |
| Drug | 2-butyl-6-methoxyphenol | 1.50e-04 | 197 | 92 | 6 | CID011954184 | |
| Drug | Doxepin hydrochloride [1229-29-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 1.54e-04 | 198 | 92 | 6 | 7415_DN | |
| Drug | pheophytin | 1.55e-04 | 284 | 92 | 7 | CID000000250 | |
| Drug | Oxybutynin chloride [1508-65-2]; Down 200; 10.2uM; PC3; HT_HG-U133A | 1.58e-04 | 199 | 92 | 6 | 7126_DN | |
| Drug | rifapentine | 1.60e-04 | 5 | 92 | 2 | ctd:C018421 | |
| Drug | 2-S-glutathionylcaffeic acid | 1.60e-04 | 5 | 92 | 2 | ctd:C082398 | |
| Drug | hydrobenzoin | 1.60e-04 | 5 | 92 | 2 | CID000095447 | |
| Drug | Tranexamic acid [1197-18-8]; Up 200; 25.4uM; PC3; HT_HG-U133A | 1.62e-04 | 200 | 92 | 6 | 5762_UP | |
| Drug | ss,ss-carotene | 1.67e-04 | 201 | 92 | 6 | CID000000573 | |
| Drug | BBCH | 1.74e-04 | 27 | 92 | 3 | CID000115288 | |
| Drug | benzyl isothiocyanate | 1.97e-04 | 71 | 92 | 4 | CID000002346 | |
| Drug | 1,2-dibromoethane | 1.97e-04 | 71 | 92 | 4 | CID000007839 | |
| Drug | CAS 87-33-2 | 2.20e-04 | 73 | 92 | 4 | CID000003780 | |
| Drug | NSC100058 | 2.31e-04 | 74 | 92 | 4 | CID000003449 | |
| Drug | stilbene oxide | 2.31e-04 | 74 | 92 | 4 | CID000028649 | |
| Drug | oltipraz | 2.37e-04 | 137 | 92 | 5 | CID000047318 | |
| Drug | 2-allylphenol | 2.40e-04 | 6 | 92 | 2 | ctd:C099328 | |
| Drug | hexylglutathione | 2.40e-04 | 6 | 92 | 2 | ctd:C033550 | |
| Drug | isomethyleugenol | 2.40e-04 | 6 | 92 | 2 | ctd:C031050 | |
| Drug | estradiol enanthate | 2.40e-04 | 6 | 92 | 2 | CID000021070 | |
| Drug | CoCl2 | 2.44e-04 | 75 | 92 | 4 | CID003015678 | |
| Drug | H088 | 2.44e-04 | 75 | 92 | 4 | CID000004542 | |
| Drug | 2,4,6-trinitrotoluene | 2.44e-04 | 75 | 92 | 4 | CID000008376 | |
| Drug | AC1O5MYK | 2.70e-04 | 77 | 92 | 4 | CID006437077 | |
| Drug | NSC9567 | 2.71e-04 | 141 | 92 | 5 | CID000003001 | |
| Drug | BP-7,8-diol | 2.83e-04 | 78 | 92 | 4 | CID000025892 | |
| Disease | Brugada syndrome (implicated_via_orthology) | 4.22e-10 | 5 | 91 | 4 | DOID:0050451 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | GSTM1 ZDHHC2 ERCC6 SACS LMO7 ESR2 CD109 ABCB11 SPNS3 DCC ABCA10 PREX2 NCDN SMAD9 | 3.23e-08 | 702 | 91 | 14 | C0009402 |
| Disease | Degenerative Diseases, Central Nervous System | 1.32e-07 | 39 | 91 | 5 | C0270715 | |
| Disease | Neurodegenerative Disorders | 1.32e-07 | 39 | 91 | 5 | C0524851 | |
| Disease | Degenerative Diseases, Spinal Cord | 1.32e-07 | 39 | 91 | 5 | C0751733 | |
| Disease | aspartate aminotransferase measurement | GSTM1 GSTM2 MRC1 LIPA PANK2 MGAT5 TTC28 ABCB11 ASTN2 LRBA SERPINA6 KIAA2012 HERPUD1 | 4.06e-06 | 904 | 91 | 13 | EFO_0004736 |
| Disease | level of glutathione S-transferase mu 1 in blood serum | 9.41e-06 | 2 | 91 | 2 | OBA_2041806 | |
| Disease | 3,7-dimethylurate measurement | 9.41e-06 | 2 | 91 | 2 | EFO_0800949 | |
| Disease | Colorectal Neoplasms | 2.46e-05 | 277 | 91 | 7 | C0009404 | |
| Disease | HDL cholesterol change measurement | 5.48e-05 | 24 | 91 | 3 | EFO_0007805 | |
| Disease | glutathione S-transferase Mu 1 measurement | 9.35e-05 | 5 | 91 | 2 | EFO_0801638 | |
| Disease | larynx cancer (is_implicated_in) | 1.40e-04 | 6 | 91 | 2 | DOID:2596 (is_implicated_in) | |
| Disease | HOMA-IR | 1.45e-04 | 33 | 91 | 3 | EFO_0004501 | |
| Disease | apolipoprotein B measurement | GSTM1 GSTM2 GSTM5 DAND5 ABCB11 SERPINA10 SERPINA6 ABCA10 HERPUD1 | 2.10e-04 | 663 | 91 | 9 | EFO_0004615 |
| Disease | hypospadias (is_implicated_in) | 2.60e-04 | 8 | 91 | 2 | DOID:10892 (is_implicated_in) | |
| Disease | Thrombophilia | 3.34e-04 | 9 | 91 | 2 | C0398623 | |
| Disease | alpha-1-antitrypsin measurement | 3.34e-04 | 9 | 91 | 2 | EFO_0008327 | |
| Disease | cholestasis (implicated_via_orthology) | 3.34e-04 | 9 | 91 | 2 | DOID:13580 (implicated_via_orthology) | |
| Disease | Diabetes, Autoimmune | 3.43e-04 | 44 | 91 | 3 | C0205734 | |
| Disease | Brittle diabetes | 3.43e-04 | 44 | 91 | 3 | C0342302 | |
| Disease | Diabetes Mellitus, Sudden-Onset | 3.43e-04 | 44 | 91 | 3 | C4554117 | |
| Disease | Diabetes Mellitus, Ketosis-Prone | 3.43e-04 | 44 | 91 | 3 | C3837958 | |
| Disease | Diabetes Mellitus, Insulin-Dependent | 3.67e-04 | 45 | 91 | 3 | C0011854 | |
| Disease | apolipoprotein B to apolipoprotein A1 ratio | 4.72e-04 | 49 | 91 | 3 | EFO_0021897 | |
| Disease | colorectal cancer (is_implicated_in) | 5.46e-04 | 121 | 91 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | obesity (implicated_via_orthology) | 5.48e-04 | 215 | 91 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | phospholipids in medium HDL measurement | 6.63e-04 | 55 | 91 | 3 | EFO_0022295 | |
| Disease | free cholesterol to total lipids in large HDL percentage | 6.99e-04 | 56 | 91 | 3 | EFO_0022279 | |
| Disease | esophageal cancer (is_implicated_in) | 7.18e-04 | 13 | 91 | 2 | DOID:5041 (is_implicated_in) | |
| Disease | Neurodegeneration with brain iron accumulation | 7.18e-04 | 13 | 91 | 2 | cv:C2931845 | |
| Disease | low density lipoprotein particle size measurement | 7.74e-04 | 58 | 91 | 3 | EFO_0008593 | |
| Disease | total lipids in medium HDL measurement | 7.74e-04 | 58 | 91 | 3 | EFO_0022310 | |
| Disease | rheumatoid arthritis (is_implicated_in) | 7.74e-04 | 58 | 91 | 3 | DOID:7148 (is_implicated_in) | |
| Disease | free cholesterol in medium HDL measurement | 7.74e-04 | 58 | 91 | 3 | EFO_0022267 | |
| Disease | cholesterol in medium HDL measurement | 8.14e-04 | 59 | 91 | 3 | EFO_0021903 | |
| Disease | phospholipids in HDL measurement | 8.97e-04 | 61 | 91 | 3 | EFO_0022293 | |
| Disease | systemic lupus erythematosus (is_implicated_in) | 9.41e-04 | 62 | 91 | 3 | DOID:9074 (is_implicated_in) | |
| Disease | dual specificity mitogen-activated protein kinase kinase 2 measurement | 1.10e-03 | 16 | 91 | 2 | EFO_0008112 | |
| Disease | ulcerative colitis (is_implicated_in) | 1.24e-03 | 17 | 91 | 2 | DOID:8577 (is_implicated_in) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.28e-03 | 152 | 91 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Autistic Disorder | 1.30e-03 | 261 | 91 | 5 | C0004352 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.31e-03 | 153 | 91 | 4 | EFO_0004611, EFO_0020946 | |
| Disease | glucose homeostasis measurement, acute insulin response measurement | 1.39e-03 | 18 | 91 | 2 | EFO_0006831, EFO_0006896 | |
| Disease | protein Z-dependent protease inhibitor measurement | 1.39e-03 | 18 | 91 | 2 | EFO_0021849 | |
| Disease | unipolar depression, bipolar disorder | 1.41e-03 | 156 | 91 | 4 | EFO_0003761, MONDO_0004985 | |
| Disease | inflammatory bowel disease (is_implicated_in) | 1.55e-03 | 19 | 91 | 2 | DOID:0050589 (is_implicated_in) | |
| Disease | Drug-Induced Liver Disease | 1.59e-03 | 404 | 91 | 6 | C0860207 | |
| Disease | Drug-Induced Acute Liver Injury | 1.59e-03 | 404 | 91 | 6 | C3658290 | |
| Disease | Hepatitis, Toxic | 1.59e-03 | 404 | 91 | 6 | C0019193 | |
| Disease | Chemically-Induced Liver Toxicity | 1.59e-03 | 404 | 91 | 6 | C4279912 | |
| Disease | Chemical and Drug Induced Liver Injury | 1.59e-03 | 404 | 91 | 6 | C4277682 | |
| Disease | Hepatitis, Drug-Induced | 1.59e-03 | 404 | 91 | 6 | C1262760 | |
| Disease | cortisol measurement | 1.72e-03 | 20 | 91 | 2 | EFO_0005843 | |
| Disease | saturated fatty acids to total fatty acids percentage | 1.90e-03 | 21 | 91 | 2 | EFO_0022305 | |
| Disease | cholangiocarcinoma (is_implicated_in) | 2.09e-03 | 22 | 91 | 2 | DOID:4947 (is_implicated_in) | |
| Disease | colorectal carcinoma (is_implicated_in) | 2.09e-03 | 22 | 91 | 2 | DOID:0080199 (is_implicated_in) | |
| Disease | N-glycan measurement | 2.09e-03 | 22 | 91 | 2 | EFO_0004999 | |
| Disease | primary open angle glaucoma (is_implicated_in) | 2.28e-03 | 23 | 91 | 2 | DOID:1070 (is_implicated_in) | |
| Disease | Dystonia | 2.41e-03 | 86 | 91 | 3 | C0013421 | |
| Disease | systemic scleroderma (is_implicated_in) | 2.48e-03 | 24 | 91 | 2 | DOID:418 (is_implicated_in) | |
| Disease | bilirubin measurement | 2.49e-03 | 442 | 91 | 6 | EFO_0004570 | |
| Disease | 3-hydroxybutyrate measurement | 2.69e-03 | 25 | 91 | 2 | EFO_0010982 | |
| Disease | response to mTOR inhibitor | 2.69e-03 | 25 | 91 | 2 | EFO_0005417 | |
| Disease | response to interferon | 2.69e-03 | 25 | 91 | 2 | EFO_0007859 | |
| Disease | macular degeneration (is_marker_for) | 2.91e-03 | 26 | 91 | 2 | DOID:4448 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FLKRWSLPGFLGSSH | 586 | Q8N1M1 | |
| SLKISGIKDFSWSPG | 461 | P55884 | |
| LSPKKTWEGFIGGFF | 271 | Q92903 | |
| GDSPLFFLKSSFWSK | 341 | Q8WWZ4 | |
| GFLGVQRKFWPATLS | 1521 | Q96Q42 | |
| PKKTWEGFIGGFFAT | 256 | O95674 | |
| KTLLAIGGWNFGTAP | 91 | Q9BZP6 | |
| STICGFLLGFFRGWK | 226 | O95342 | |
| LKFSTGGDKPAIWLD | 161 | P48052 | |
| TFPILFIGWGSQSSK | 41 | O60706 | |
| VSIKSFFQPWLGDTG | 71 | Q5JTW2 | |
| DSGTAIFLKPWSKGN | 61 | P29016 | |
| KLFFNGRPGIVAWTL | 236 | Q9UBM7 | |
| WSLFDFIFPGKLGTL | 686 | Q03468 | |
| TFSLGQGLWLPVSKS | 586 | O75129 | |
| LSPCLAWSFLKAGFA | 301 | Q96I13 | |
| QFPFALLGWTGSKLF | 426 | Q9NP87 | |
| LWGLSGSLVAPAFKV | 481 | Q7Z6P3 | |
| NSSLPGVFKKSDGWV | 86 | O95980 | |
| WLVFKTFFASLLPEG | 371 | Q15011 | |
| FLIITSAWGGSKGPL | 11 | P05546 | |
| LGIFLFLCSTPAWAK | 6 | P00450 | |
| PFVFSLGKGQVIKAW | 76 | Q13451 | |
| FGENTKPWLSGFSVA | 271 | Q96H96 | |
| LVPASALGSWKAFLG | 51 | Q8N907 | |
| PNNLWYLFTGLEKGS | 676 | P43146 | |
| SWAKKIPGFVELSLF | 311 | Q92731 | |
| WIPAGSSGSKFLALL | 296 | Q9UBB6 | |
| AFWKEGAGNKTLFPV | 161 | Q8IU57 | |
| FLGKRPWFAGDKITF | 141 | P46439 | |
| KSLYGFFWKQPGTLE | 346 | Q09327 | |
| PWKLSSQKLGFFLVT | 6 | Q09328 | |
| SSFSISWLPFKGLAN | 436 | Q6ZRQ5 | |
| KSPATFGLSGLWTLE | 101 | Q6ZVZ8 | |
| KGEPFWVNLGLLLFS | 506 | O75387 | |
| IAKTGSGKTAAFIWP | 296 | Q86XP3 | |
| GVTGSFKDKPLAEWL | 1201 | O00443 | |
| FLGKQPWFLGDKITF | 141 | P28161 | |
| WSLFLPKTFSTRKGA | 56 | Q0VF49 | |
| LFFSKLQGDKGRWPP | 171 | P50851 | |
| KSLDFGFTIKWDIPG | 1051 | Q8WWI1 | |
| GTFSLRKLWAFTGPG | 51 | P49279 | |
| ILTKSGAWFFGSGPQ | 171 | Q86UR5 | |
| FPWFGLDIGGTLVKL | 211 | Q9BZ23 | |
| SPKLWILVLGAVFGF | 326 | O43826 | |
| KGDVTLTFLPLSFWG | 261 | Q6YHK3 | |
| QGAFEKIFSLWPLSK | 571 | Q96PB1 | |
| SGLWSLPGGKDTILF | 286 | Q6ZUS6 | |
| LSQKVFGTLFGLLSW | 216 | Q8N6M3 | |
| TNWPLLTVSKGFFEG | 806 | P53621 | |
| SWSSLNPKFLSGKGL | 36 | P98172 | |
| TIFLGFSGNFKPSWT | 1321 | Q9UHN6 | |
| KTLNKLGVPFWLSSG | 286 | O75072 | |
| KEFLGLSPFSLIKGW | 381 | Q7Z4H7 | |
| WTLIFGDPTKFGLGV | 326 | O60931 | |
| LPFLTKPAGFSLDWK | 2216 | Q9NZJ4 | |
| IFFKGTWTQPFDLAS | 201 | P08185 | |
| VWGRKPFLLGTVFFT | 106 | Q5VZR4 | |
| VWGRKPFLLGTVFFT | 106 | Q5SR56 | |
| LLVIWGEGKFPSAAS | 6 | Q96DY7 | |
| LSLKPSWFDFGFAIL | 371 | Q96PC5 | |
| GFSDLKALQGPLFWV | 16 | Q8NGE3 | |
| STSTIPKLLGIFWFG | 76 | Q8NGK5 | |
| KLFWLGLTYGSPSEG | 711 | P22897 | |
| TFLGQNKSFWGPLEL | 121 | Q7L099 | |
| GIGSLLPWNFFITAK | 61 | Q9BZD2 | |
| GSGSLWTTKFFIPLT | 336 | Q9BZD2 | |
| SPKGWLVDLLNKFGT | 216 | Q93008 | |
| LKWPILGQLFFSSKF | 216 | Q68CQ4 | |
| FLGKRPWFVGDKITF | 141 | Q03013 | |
| FLGKRPWFAGNKITF | 141 | P09488 | |
| VFKLWPLSFLGSKLS | 231 | Q9BRB3 | |
| LAESFPFWASKGKLE | 461 | Q6ZUB0 | |
| FVKASASLKGQPWGL | 2226 | Q9P2P6 | |
| FTKAAPFGVLWTLTN | 151 | Q8IY50 | |
| SLGQFSSLGPLAVWK | 96 | Q99884 | |
| LAVWKISPLFKGAGA | 106 | Q99884 | |
| FSFTSPAVKRLLGWK | 11 | O15198 | |
| SKFQGPKLSTSGFEW | 4626 | Q8IVF2 | |
| WFRFPKLGFSSSPTK | 5696 | Q8IVF2 | |
| LAESFPFWASKGKLE | 461 | P0C874 | |
| LLAGQKKSSPFWTFE | 66 | Q9Y548 | |
| NAKPDWLKVGFTLGT | 36 | O43677 | |
| AFVTGALGFWAPKFL | 271 | Q6ZMD2 | |
| LTAPGLSWKKFQGSF | 36 | Q8TBR4 | |
| LLAPSDVAGWGTFIK | 616 | Q92800 | |
| KPKFWENLTSPLFGT | 1006 | Q5SRE5 | |
| FPKCFLGSEFVSWLL | 406 | Q70Z35 | |
| LWSKPLNSFGPGEFL | 686 | P08922 | |
| ILFKGKWLTPFDPVF | 236 | Q9UK55 | |
| LYSWLLAPGAGIVKF | 1246 | Q96AY4 | |
| KNGLSLGFPFSRPFW | 156 | O95201 | |
| PLGVIWGKFSEFYSK | 231 | Q8WVY7 | |
| KKYWLLPIFSSLGDG | 276 | Q9UIJ5 | |
| FKGSQFAIRWGFIPL | 16 | Q9P0U1 | |
| WVSIDGASFLKIFGP | 31 | O60635 | |
| KEFLPQSAFLKWLGT | 231 | P38571 | |
| KSGGPAFTIGKSVWL | 591 | Q14957 |